Znanstveni rad - Izvorni znanstveni rad
Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study
Diabetes Therapy, 9 (2018), 6; 2315-2324. https://doi.org/10.1007/s13300-018-0517-y


Citirajte ovaj rad

Baretić, M., Kušec, V. i Pavlić Renar, I. (2018). Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study. Diabetes Therapy, 9. (6), 2315-2324. doi: 10.1007/s13300-018-0517-y

Baretić, Maja, et al. "Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study." Diabetes Therapy, vol. 9, br. 6, 2018, str. 2315-2324. https://doi.org/10.1007/s13300-018-0517-y

Baretić, Maja, Vesna Kušec i Ivana Pavlić Renar. "Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study." Diabetes Therapy 9, br. 6 (2018): 2315-2324. https://doi.org/10.1007/s13300-018-0517-y

Baretić, M., Kušec, V. i Pavlić Renar, I. (2018) 'Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study', Diabetes Therapy, 9(6), str. 2315-2324. doi: 10.1007/s13300-018-0517-y

Baretić M, Kušec V, Pavlić Renar I. Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study. Diabetes Therapy [Internet]. 12.2018. [pristupljeno 07.11.2024.];9(6):2315-2324. doi: 10.1007/s13300-018-0517-y

M. Baretić, V. Kušec i I. Pavlić Renar, "Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study", Diabetes Therapy, vol. 9, br. 6, str. 2315-2324, Prosinac 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:346112. [Citirano: 07.11.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.